ISELIN, NJ, Dec. 3, 2012 /CNW/ - Ansell, a global leader in protection
solutions today announced the latest addition to its Active Infection
Protection (AIP) portfolio, the GAMMEX N95 Respirator and Surgical
Mask, extending the AIP range beyond surgical gloves. This new mask is
the first to utilize a hybrid technology that incorporates the comfort
of a standard surgical mask with the protection of a respirator. The
mask is designed to more comfortably protect healthcare workers and
patients from harmful airborne pathogens, therefore reducing the risk
of Healthcare Associated Infection (HAI).
The GAMMEX N95 Respirator and Surgical Mask filters out 95% of airborne
particles down to 0.1 micron in size, exceeding the worldwide standard
for respirators of 0.3 microns set by the National Institute for
Occupational Safety and Health (NIOSH), US FDA, and Health Canada. This
allows the mask to remove many airborne particles contained in surgical
smoke and filter out 99.9% of airborne viruses and bacterial
microorganisms. Its high filtration capability, combined with TYPE II
fluid resistance, makes the new GAMMEX N95 Respirator and Surgical Mask
a critical component in personal protection for Infection Control,
Isolation, ICU, ER, OR and many other areas subject to airborne
pathogens and harmful particles.
The GAMMEX N95 Respirator and Surgical Mask is designed for unrivalled
comfort and performance. Its patented Breathable Face Seal allows air
to circulate through the top, bottom and sides of the respirator,
ensuring maximum breathability. The unique design feels lighter and
cooler so it can be worn comfortably for longer periods of time,
promoting compliance and further enhancing infection prevention.
"This addition to the Ansell Active Infection Protection portfolio,
coupled with our antimicrobial surgical gloves and a series of products
currently in our pipeline, demonstrates our commitment to delivering
clinically relevant solutions in infection prevention to help in the
fight against healthcare associated infections," said Anthony B. Lopez, President and General Business Manager, Ansell
"In line with our focus on innovation, the GAMMEX N95 Respirator and
Surgical Mask provides a unique technological solution, specialized for
the demands of the healthcare environment where exposure to airborne
pathogens is high," he continued.
The GAMMEX brand offers the most innovative and technologically advanced
solutions worldwide, protecting against external aggression, allergic
reactions and microbial contamination in the perioperative environment.
The GAMMEX N95 Respirator and Surgical Mask is now available for sale
in North America, with global rollout to follow in 2013.
Ansell is a world leader in providing superior health and safety
protection solutions that enhance human wellbeing. With operations in
North America, Latin America/Caribbean, EMEA and Asia, Ansell employs
more than 10,000 people worldwide and holds leading positions in the
personal protective equipment and medical gloves market, as well as in
the sexual health and wellbeing category worldwide. Ansell operates in
four main business segments: Medical Solutions, Industrial Solutions,
Specialty Markets and Sexual Wellness.
Information on Ansell and its products can be found at http://www.ansell.com
Ansell Protected | HyFlex, GAMMEX, SKYN and ACTIVARMR are trademarks
owned by Ansell Limited or one of its affiliates.
® and ™ are owned by Ansell Limited or one of its affiliates.
© 2012 Ansell Limited. All rights reserved.
SOURCE: Ansell Healthcare
For further information:
Ansell Media Relations: Frank Mantero, GC - Ansell, Tel: +1-732-345-2128/ +1-908770-3595, email@example.com ; Ansell Investor Relations: David Graham, I.R. -Ansell, Tel: +1-613-9270-7215 / +1-61-4011-407-49, firstname.lastname@example.org